-
© Max-Planck-GesellschaftMinerva Scientific Director Ulman Lindenberger bids farewell after 5 intense years
Ulman Lindenberger bids farewell after five years as Scientific Director of the Minerva Foundation. In his farewell address he looks back on an intense time. His successor will be Christian Doeller.
-
© Arnell Koegelenberg/peopleimages.com – stock.adobe.com Award winners of the Simom Peres Prize 2025
he 2025 Shimon Peres Prize has been awarded to two civil society initiatives whose projects make a sustainable contribution to understanding, empathy and exchange.
-
© Ekaterine – stock.adobe.comState Secretary Marcus Pleyer visits Israel
Marcus Pleyer, State Secretary in the Ministry of Research, Technology and Space (BMFTR), vitited Israel at the beginning of December to attend the 42nd meeting of the Board of Trustees of the German-Israeli Foundation for Scientific Research and Development (GIF). During his trip he also visited other key partners of the BMFTR.
-
© ODES / pikovit – stock.adobe.comPreliminary Announcement: EP MerMed Joint Transnational Call 2026
CARMEN 2026, a joint call by the European Partnership for Personalised Medicine (EP PerMed) adressing cardiovascular, metabolic, and kidney diseases, will open on 25 November 2025. Funding organisations from both Israel and Germany are involved in this call.
-
© Max-Planck-GesellschaftNew Max Planck Center brings together researchers from Freiburg and Jerusalem
On 11 November 2025, the Max Planck Center for Democracy, Security and Human Rights was inaugurated at the Hebrew University of Jerusalem. It tackles questions like: How can societies defend themselves without destroying the democratic and rule of law values they seek to protect?
-
© Ekaterine – stock.adobe.com
Thuringia’s Prime Minister Mario Voigt and high ranking delegation travel to Israel
Thuringia’s Minister-President Mario Voigt travels to Israel with a high-ranking delegation from 9 to 13 November 2025. The trip will take him to Tel Aviv and Jerusalem under the motto ‘Research. Innovation. Partnership / Thuringia and Israel – shaping the future, living solidarity and strengthening friendships’.
-
© catalin – stock.adobe.comStudy finds protein target that could predict drug resistance in colon cancer
A German-Israeli research team has uncovered a promising new avenue in treating colorectal cancer, the world’s third leading cause of cancer-related deaths. The scientists identified a protein system that could open the door to more tailored, effective treatments.
-
© Shahid – stock.adobe.com German-Israeli research team investigates biofilms
Bacteria use surfaces to form complex heterogeneous communities known as biofilms. How these biofilms develop is the subject of a new international research project supported by the German Research Foundation (DFG) and the Israel Science Foundation (ISF).
-
© Gohgah – stock.adobe.comNovel technique shines light on next-gen nanomaterials: how MXenes truly work
Researchers from Israel and Germany have for the first time measured the true properties of individual MXene flakes — an exciting new nanomaterial with potential for better batteries, flexible electronics, and clean energy devices.
-
© Max-Planck-Gesellschaft
Lou Bohlen presents the work of the Israel team at the Headquarters of the MPG
Lou Bohlen presented the Minerva team’s work during a presentation at the Max Planck Society, discussing the impact of the past two years of war on their operations. Over 70 participants attended, highlighting interest in their efforts.
